MDGL vs SCHW · rev $675.6M vs P/E 19, rev $13.55B
Madrigal Pharmaceuticals Inc (MDGL) versus Charles Schwab Corp (SCHW) — a side-by-side from cached financials, not a winner call.
Madrigal Pharmaceuticals Inc (MDGL) is a biotechnology company listed on NASDAQ.
Charles Schwab Corp (SCHW) is a capital markets company listed on NYSE. It is led by Walt Bettinger.
Latest reported MDGL revenue for 2026-06-30 was $675.6M. Net income was -$152.3M. MDGL currently screens at market cap $11.56B.
Latest reported SCHW revenue for 2026-06-30 was $13.55B. Net income was $5.28B. SCHW currently screens at market cap $164.37B and trailing P/E 18.8.
MDGL currently screens at market cap $11.56B. SCHW currently screens at market cap $164.37B and trailing P/E 18.8.
Not investment advice. Open the MDGL and SCHW stock pages for the full models.
Not investment advice.